BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 27160772)

  • 1. Association of Vasculogenic Mimicry Formation and CD133 Expression with Poor Prognosis in Ovarian Cancer.
    Liang J; Yang B; Cao Q; Wu X
    Gynecol Obstet Invest; 2016; 81(6):529-536. PubMed ID: 27160772
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant expression of CD133 in non-small cell lung cancer and its relationship to vasculogenic mimicry.
    Wu S; Yu L; Wang D; Zhou L; Cheng Z; Chai D; Ma L; Tao Y
    BMC Cancer; 2012 Nov; 12():535. PubMed ID: 23170850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significances and prognostic value of cancer stem-like cells markers and vasculogenic mimicry in renal cell carcinoma.
    Zhang Y; Sun B; Zhao X; Liu Z; Wang X; Yao X; Dong X; Chi J
    J Surg Oncol; 2013 Nov; 108(6):414-9. PubMed ID: 23996537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Correlation between bacterial L-form infection, expression of HIF-1α/MMP-9 and vasculogenic mimicry in epithelial ovarian cancer].
    Yu L; Wu SW; Zhou L; Song WQ
    Sheng Li Xue Bao; 2012 Dec; 64(6):657-65. PubMed ID: 23258329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD133 and CD117 in 64 Serous Ovarian Cancer Cases.
    Stemberger-Papić S; Vrdoljak-Mozetic D; Ostojić DV; Rubesa-Mihaljević R; Krigtofić I; Brncić-Fisher A; Kragević M; Eminović S
    Coll Antropol; 2015 Sep; 39(3):745-53. PubMed ID: 26898076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia promotes vasculogenic mimicry formation by inducing epithelial-mesenchymal transition in ovarian carcinoma.
    Du J; Sun B; Zhao X; Gu Q; Dong X; Mo J; Sun T; Wang J; Sun R; Liu Y
    Gynecol Oncol; 2014 Jun; 133(3):575-83. PubMed ID: 24589413
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD133 expression associated with poor prognosis in ovarian cancer.
    Zhang J; Guo X; Chang DY; Rosen DG; Mercado-Uribe I; Liu J
    Mod Pathol; 2012 Mar; 25(3):456-64. PubMed ID: 22080056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlation of vasculogenic mimicry with clinicopathologic features and prognosis of ovarian carcinoma].
    Gao Y; Zhao XL; Gu Q; Wang JY; Zhang SW; Zhang DF; Wang XH; Zhao N; Gao YT; Sun BC
    Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):585-9. PubMed ID: 20079185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between CD177 and the vasculogenic mimicry, clinicopathological parameters, and prognosis of epithelial ovarian cancer.
    Jiang J; Chen Y; Zhang M; Zhou H; Wu H
    Ann Palliat Med; 2020 Nov; 9(6):3985-3992. PubMed ID: 33302660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum sensitivity and CD133 expression as risk and prognostic predictors of central nervous system metastases in patients with epithelial ovarian cancer.
    Liu BL; Liu SJ; Baskys A; Cheng H; Han Y; Xie C; Song H; Li J; Xin XY
    BMC Cancer; 2014 Nov; 14():829. PubMed ID: 25399490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Wnt5a promotes vasculogenic mimicry and epithelial-mesenchymal transition via protein kinase Cα in epithelial ovarian cancer.
    Qi H; Sun B; Zhao X; Du J; Gu Q; Liu Y; Cheng R; Dong X
    Oncol Rep; 2014 Aug; 32(2):771-9. PubMed ID: 24898696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the clonal evolution of CD133/aldehyde-dehydrogenase-1 (ALDH1)-positive cancer stem-like cells from primary to recurrent high-grade serous ovarian cancer (HGSOC). A study of the Ovarian Cancer Therapy-Innovative Models Prolong Survival (OCTIPS) Consortium.
    Ruscito I; Cacsire Castillo-Tong D; Vergote I; Ignat I; Stanske M; Vanderstichele A; Ganapathi RN; Glajzer J; Kulbe H; Trillsch F; Mustea A; Kreuzinger C; Benedetti Panici P; Gourley C; Gabra H; Kessler M; Sehouli J; Darb-Esfahani S; Braicu EI
    Eur J Cancer; 2017 Jul; 79():214-225. PubMed ID: 28525846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expressions of CD133, E-cadherin, and Snail in epithelial ovarian cancer and their clinicopathologic and prognostic implications].
    Yu L; Zhou L; Wu S; Song W; Cheng Z; Guo B
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Aug; 35(9):1297-302. PubMed ID: 26403742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aberrant Expression of Markers of Cancer Stem Cells in Gastric Adenocarcinoma and their Relationship to Vasculogenic Mimicry.
    Zhou L; Yu L; Feng ZZ; Gong XM; Cheng ZN; Yao N; Wang DN; Wu SW
    Asian Pac J Cancer Prev; 2015; 16(10):4177-83. PubMed ID: 26028069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinicopathological parameters significance of CD133 and Nestin in epithelial ovarian cancer: a meta-analysis.
    Zhao L; Li J; Liu M; Zhou H; Zou H; Wei Y; Sun K; Li G; Li S; Pang L
    Future Oncol; 2017 Dec; 13(28):2555-2570. PubMed ID: 29168665
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The expression levels and clinical significance of MFG-E8 and CD133 in epithelial ovarian cancer.
    Li N; Dai C; Yang Y; Wu X; Wang L; Wang P
    Gynecol Endocrinol; 2020 Sep; 36(9):803-807. PubMed ID: 31899997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF and SEMA4D have synergistic effects on the promotion of angiogenesis in epithelial ovarian cancer.
    Chen Y; Zhang L; Liu WX; Wang K
    Cell Mol Biol Lett; 2018; 23():2. PubMed ID: 29308068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vasculogenic mimicry in human gliomas.
    Liu XM; Zhang QP; Mu YG; Zhang XH; Sai K; Pang JC; Ng HK; Chen ZP
    J Neurooncol; 2011 Nov; 105(2):173-9. PubMed ID: 21533525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasticity of ovarian cancer cell SKOV3ip and vasculogenic mimicry in vivo.
    Su M; Feng YJ; Yao LQ; Cheng MJ; Xu CJ; Huang Y; Zhao YQ; Jiang H
    Int J Gynecol Cancer; 2008; 18(3):476-86. PubMed ID: 17645504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD133+ cancer stem-like cells promote migration and invasion of salivary adenoid cystic carcinoma by inducing vasculogenic mimicry formation.
    Wang SS; Gao XL; Liu X; Gao SY; Fan YL; Jiang YP; Ma XR; Jiang J; Feng H; Chen QM; Tang YJ; Tang YL; Liang XH
    Oncotarget; 2016 May; 7(20):29051-62. PubMed ID: 27074560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.